English
Polski
Español
українська
Molnupiravir for COVID-19: Hopes and concerns
Dr Bram Rochwerg and Dr Roman Jaeschke scrutinize current evidence on the use of a novel drug in the early treatment of COVID-19.
2021-12-30
Dr Bram Rochwerg and Dr Roman Jaeschke scrutinize current evidence on the use of a novel drug in the early treatment of COVID-19.
Dr Simon Oczkowski and Dr Roman Jaeschke discuss the role of palliative care consultations in the ICU and post-ICU management of sepsis survivors.
A discussion from behind the scenes on the Surviving Sepsis Campaign 2021 guidelines between Dr Morten Hylander Møller and Dr Roman Jaeschke.
Dr Fayez Alshamsi from United Arab Emirates University comments on fluid and antibiotic administration in patients with sepsis.
Dr Fayez Alshamsi from United Arab Emirates University elucidates recommendations on the use of capillary refill time and lactate levels in sepsis.
Dr Jean-Louis Vincent comments on the latest Surviving Sepsis Campaign 2021 guidelines.
Dr Jean-Louis Vincent joins Dr Roman Jaeschke in the newest McMaster Perspective episode to scrutinize the latest Surviving Sepsis Campaign 2021 guidelines and share his clinical experience.
Dr Ryan Zarychanski from University of Manitoba, Canada, joins Dr Roman Jaeschke to discuss the latest trial results regarding anticoagulation in noncritically ill patients with COVID-19.
Dr Ryan Zarychanski from University of Manitoba, Canada, joins Dr Roman Jaeschke to discuss the latest trial results regarding anticoagulation in critically ill patients with COVID-19.
Dr Roman Jaeschke, an intensivist, and Dr James Douketis, an expert in thrombosis, discuss the paradigm-changing results of the latest clinical trials on therapeutic anticoagulation in patients with COVID-19.
